Krishnan Nandabalan

Insider Reports History

Location
Guilford, CT
Signature
/s/ Krishnan Nandabalan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Krishnan Nandabalan:

Company Role Class Num Shares Value Price $ Report Date Ownership
BioXcel Therapeutics, Inc. Director, 10%+ Owner Common Stock 8,546,750 $22,401,886 $2.62 06 Apr 2023 Indirect
BioXcel Therapeutics, Inc. Director, 10%+ Owner Stock Options 294,000 06 Apr 2023 Direct
BioXcel Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 06 Apr 2023 Direct

Insider Reports Filed by Krishnan Nandabalan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BTAI BioXcel Therapeutics, Inc. 06 Apr 2023 3 -$1,014,600 4 Director, 10%+ Owner 10 Apr 2023, 18:20
BTAI BioXcel Therapeutics, Inc. 04 Jan 2023 8 -$1,296,276 4 Director, 10%+ Owner 06 Jan 2023, 19:00
BTAI BioXcel Therapeutics, Inc. 31 Dec 2022 3 $0 5 Director 14 Feb 2023, 15:44
BTAI BioXcel Therapeutics, Inc. 10 Nov 2022 6 -$875,400 4 Director, 10%+ Owner 14 Nov 2022, 19:00
BTAI BioXcel Therapeutics, Inc. 31 Dec 2021 4 $0 5 Director 14 Feb 2022, 16:37
BTAI BioXcel Therapeutics, Inc. 25 Jun 2021 1 -$14,589,493 4 Director 29 Jun 2021, 17:23